Sign in

CIK 0001437402

  • Large accelerated filer

ARDELYX, INC.

Sign in to watch
Ticker
ARDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-745-7047
Business address
34175 ARDENWOOD BLVD., FREMONT, CA, 94555
Former names
NTERYX INC
  1. 4 Planned sale Chief Patient Officer sold 80,000 shares at $6.12 ($489,680)
  2. 4 Open-market sale Chief Business Officer sold 5,417 shares at $5.93 ($32,132)
  3. 4 Open-market sale Chief Patient Officer sold 6,261 shares at $5.93 ($37,138)
  4. 4 Open-market sale Chief Financial Officer sold 7,037 shares at $5.93 ($41,741)
  5. 4 Open-market sale President & CEO sold 45,687 shares at $5.93 ($271,002)
  6. 4 Open-market sale See Remarks sold 5,841 shares at $5.93 ($34,647)
  7. 4 Open-market sale Chief Commercial Officer sold 15,308 shares at $5.93 ($90,802)
  8. 4 Grant or award Director acquired 41,551 shares (grant or award)
  9. 4 Grant or award Director acquired 63,019 shares (grant or award)
  10. 4 Grant or award Director acquired 15,235 shares (grant or award)
  11. 4 Grant or award Director acquired 72,714 shares (grant or award)
  12. 4 Grant or award Director acquired 41,551 shares (grant or award)
  13. 4 Grant or award Director acquired 41,551 shares (grant or award)
  14. 4 Grant or award Director acquired 60,941 shares (grant or award)
  15. 4 Open-market buy Director bought 200,000 shares at $3.63 ($725,880)
  16. 4 Open-market buy Director bought 200,000 shares at $3.69 ($737,260)
  17. 4 Open-market sale Chief Medical Officer sold 6,421 shares at $4.08 ($26,207)
  18. 4 Open-market sale Chief Financial Officer sold 7,218 shares at $4.08 ($29,460)
  19. 4 Open-market sale President & CEO sold 46,817 shares at $4.08 ($191,079)
  20. 4 Open-market sale See Remarks sold 14,522 shares at $4.08 ($59,270)

Page 4 of 35 · 690 filings